$AXGN 4/A SEC Filings

Filed On	Filing
05 Mar 2025	Form 4/A: Kemp Jens, Chief Marketing Officer Received 2,500 shares by exercise or conversion · Gave up 814 shares to cover exercise price or tax ($13.4K)
07 Jun 2021	Form 4/A: Neels Guido J, Director Received 40,000 shares by exercise or conversion ($171K)
12 Jun 2020	Form 4/A: Rudelius Robert James, Director Granted 12,605 Stock Option (right to purchase) · Granted 6,173 Restricted Stock Units
12 Jun 2020	Form 4/A: Neels Guido J, Director Granted 12,605 Stock Option (right to purchase) · Granted 6,173 Restricted Stock Units
12 Jun 2020	Form 4/A: Wendell Amy McBride, Director Granted 12,605 Stock Option (right to purchase) · Granted 6,173 Restricted Stock Units
12 Jun 2020	Form 4/A: Levine Alan M, Director Granted 12,605 Stock Option (right to purchase) · Granted 6,173 Restricted Stock Units
12 Jun 2020	Form 4/A: Blackford Quentin S., Director Granted 12,605 Stock Option (right to purchase) · Granted 6,173 Restricted Stock Units
12 Jun 2020	Form 4/A: Gold Mark Stephen, Director Granted 12,605 Stock Option (right to purchase) · Granted 6,173 Restricted Stock Units
05 Jun 2020	Form 4/A: Blackford Quentin S., Director Bought 1,365 shares ($17.9K) · Bought 14,170 shares ($200K)
16 Feb 2018	Form 4/A: Grooms Jamie Mark, Director Sold 10,300 shares ($270K) · Sold 42,009 shares ($1.12M) · Sold 43,403 shares ($1.18M)
13 Dec 2017	Form 4/A: Grooms Jamie Mark, Director Sold 21,290 shares ($558K) · Sold 33,500 shares ($887K) · Sold 31,805 shares ($839K)
31 May 2016	Form 4/A: Donovan Michael Patrick, VP Operations Granted 10,000 Employee Stock Option (right to purchase)
31 May 2016	Form 4/A: Engels John P, VP Granted 8,500 Employee Stock Option (right to purchase)
31 May 2016	Form 4/A: Mandato Joseph M, Director Granted 15,000 Stock Option (right to purchase)
31 May 2016	Form 4/A: Gold Mark Stephen, Director Granted 15,000 Stock Option (right to purchase)
31 May 2016	Form 4/A: Grooms Jamie Mark, Director Granted 15,000 Stock Option (right to purchase)
31 May 2016	Form 4/A: Hansen David K, Chief Accounting Officer Granted 25,000 Employee Stock Option (right to purchase)
31 May 2016	Form 4/A: DeVinney Erick Wayne, VP, Clinical&Translational Sc Granted 20,000 Employee Stock Option (right to purchase)
31 May 2016	Form 4/A: Leach Kevin, Vice President Marketing Granted 160,000 Employee Stock Option (right to purchase)
31 May 2016	Form 4/A: Donovan Michael Patrick, VP Operations Granted 25,000 Employee Stock Option (right to purchase)

Comments